Cart
sales@molnova.com
[Asp5,6,Me-Phe8] Substance P
CAS No. ———
[Asp5,6,Me-Phe8] Substance P( ——— )
Catalog No. M41629 CAS No. ———
[Asp5,6,Me-Phe8] Substance P
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Asp5,6,Me-Phe8] Substance P
-
NoteResearch use only, not for human use.
-
Brief Description[Asp5,6,Me-Phe8] Substance P
-
Description[Asp5,6,Me-Phe8] Substance P
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight857
-
Molecular FormulaC40H56N8O11S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tokinolide B
Tokinolide B may have sedative and spasmolytic properties.
-
Pomalidomide 4'-PEG2...
Pomalidomide 4'-PEG2-azide is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a linker.
-
GSK-626616
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
